EDGAR ENGLEMAN

Insider Reports History

Location
Palo Alto, CA
Signature
/s/ William P. Quinn, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by EDGAR ENGLEMAN:

Company Role Class Num Shares Value Price $ Report Date Ownership
Bolt Biotherapeutics, Inc. Director Common Stock 1,821,483 $1,730,409 $0.95 30 Nov 2023 By Vivo Capital Fund VIII, L.P.
Bolt Biotherapeutics, Inc. Director Common Stock 251,522 $238,946 $0.95 30 Nov 2023 By Vivo Capital Surplus Fund VIII, L.P.
Bolt Biotherapeutics, Inc. Director Stock Option (Right to Buy) 25,000 12 Jun 2023 Direct

Insider Reports Filed by EDGAR ENGLEMAN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BOLT Bolt Biotherapeutics, Inc. 29 Nov 2023 4 -$128,993 4 Director 01 Dec 2023, 12:31
BOLT Bolt Biotherapeutics, Inc. 21 Nov 2023 2 -$1,751 4 Director 22 Nov 2023, 19:45
BOLT Bolt Biotherapeutics, Inc. 16 Nov 2023 6 -$45,675 4 Director 20 Nov 2023, 21:31
BOLT Bolt Biotherapeutics, Inc. 12 Jun 2023 1 $0 4 Director 14 Jun 2023, 17:13
BOLT Bolt Biotherapeutics, Inc. 10 Jun 2022 1 $0 4 Director 10 Jun 2022, 18:11
BOLT Bolt Biotherapeutics, Inc. 24 Mar 2022 1 $0 4 Director 28 Mar 2022, 15:21